Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $4.97
  • 52 Week High: $133.10
  • 52 Week Low: $92.92
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 0
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 129.11
Closing Price Change $ 4.97
% Change 0.00 %
52 Week High $133.10
52 Week Low $92.92
Volume 0
Shares Issued 1,246.00m
RiskGrade 120

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 5
Sell 1
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 22-Jan-2026

Time Volume / Share Price
10:56 100 @ $132.74
10:56 100 @ $132.72
10:56 103 @ $132.69
10:56 100 @ $132.72
10:56 200 @ $132.72

Top of Page